Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Dan P who wrote (1344)	11/2/1999 11:13:00 AM
From: out_of_the_loop	Respond to of 5582

Dan: Not that I am aware of, except that indirectly the first study did that. Since I buy the proposed mechanism of action, I believe it would. The second study will clear that up indirectly, I think. Your specific question is harder to quantify than starting from ground zero. That actually is precisely why the first study is so compelling to me, despite what have been criticized as flaws (using symptoms only to define a cold rather than a known infection at a known time with a known amount of a known agent). Frankly, if the p value had been toward the .o5 level I would not have been impressed or found it compelling but at < 0.001, I found it so. Regards, Howard